Reproducibility of novel immune-inflammatory biomarkers over 4 months: an analysis with repeated measures design

Biomark Med. 2019 Jun;13(8):639-648. doi: 10.2217/bmm-2018-0351. Epub 2019 Jun 3.

Abstract

Aim: Assessment of the feasibility and reliability of immune-inflammatory biomarker measurements. Methods: The following biomarkers were assessed in 207 predominantly healthy participants at baseline and after 4 months: MMF, TGF-β, suPAR and clusterin. Results: Intraclass correlation coefficients (95% CIs) ranged from good for TGF-β (0.75 [95% CI: 0.33-0.90]) to excellent for MMF (0.81 [95% CI: 0.64-0.90]), clusterin (0.83 [95% CI: 0.78-0.87]) and suPAR (0.91 [95% CI: 0.88-0.93]). Measurement of TGF-β was challenged by the large number of values below the detection limit. Conclusion: Single measurements of suPAR, clusterin and MMF could serve as feasible and reliable biomarkers of immune-inflammatory pathways in biomedical research.

Keywords: MMF; TGF-β; clusterin; immune-inflammatory biomarkers; repeated measures design; reproducibility; suPAR.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Blood Chemical Analysis / methods*
  • Body Mass Index
  • Clusterin / blood
  • Female
  • Humans
  • Inflammation / blood
  • Inflammation / immunology
  • Limit of Detection
  • Male
  • Middle Aged
  • Time Factors
  • Transforming Growth Factor beta / blood
  • Waist Circumference

Substances

  • Clusterin
  • Transforming Growth Factor beta